STA
PGNX

Summit Trail Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Summit Trail Advisors’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-73,366
Closed -$408K – 715
2018
Q1 		$408K Buy
73,366
+8,495
+13% +$47.2K 0.07% 233
2017
Q4 		$424K Buy
+64,871
New +$424K 0.05% 254